medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2005, Número 5

<< Anterior Siguiente >>

Rev Invest Clin 2005; 57 (5)


Peritonitis secundaria

González-Ojeda A, Velázquez-Ramírez GA

Idioma: Español
Referencias bibliográficas: 44
Paginas: 706-715
Archivo PDF: 76.99 Kb.


FRAGMENTO

CASO CLÍNICO

Paciente masculino de 38 años de edad, casado, agricultor, con antecedente de consumo tabáquico intenso por 10 años, 30 cigarrillos diarios, ingesta alcohólica frecuente hasta la embriaguez y consumidor de cocaína de manera ocasional. Conocido con enfermedad por reflujo gastroesofágico y hernia hiatal de un año de evolución con manifestaciones típicas (pirosis frecuentes, dolor epigástrico), previa a la evaluación prequirúrgica que consistió en una serie esófago-gastro-duodenal, endoscopia superior y biopsias de esófago distal con esofagitis péptica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Gorbach SL. Intra-abdominal infections: state of the art clinical article. Clin Infect Dis 1993; 17: 961-7.

  2. Rotstein OD, Meakins JL. Diagnostic and therapeutic challenges of intra-abdominal infections. World J Surg 1990; 14: 159-66.

  3. Bochud PY, Calandra T. Pathogenesis of Sepsis. New concepts and implications for future therapy. BMJ 2003; 326: 262-6.

  4. Emmanuel K, Weighaedt H, Bartels H, Siewert JR, Holzmann B. Current and future concepts of abdominal sepsis. World J Surg 2005; 29: 3-9.

  5. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest 1992; 101: 1644-55.

  6. Carrillo-Esper R, Carvajal-Ramos R. Sepsis. Conceptos actuales (Primera de tres partes). Rev Fac Med UNAM 2004; 47: 238-45.

  7. Cunneen J, Cartwright M. The Puzzle of Sepsis: Fitting the pieces of the inflammatory response with treatment. AACN Clin Issues 2004; 15: 18-44.

  8. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23: 1638-52.

  9. Pacelli F, Doglietto GB, Alfieri S, Piccioni E, Sgadari A, Gui D, et al. Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients. Arch Surg 1996; 131: 641-5.

  10. Bosscha K, Reijnders K, Hulstaert PF, Algra A, Van Der Werken C. Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis. Br J Surg 1997; 84: 1532-4.

  11. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 1995; 273: 117-23.

  12. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, for the Early Goal Directed Therapy Collaborative Group. Early Goal-Directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77.

  13. Wittmann DH, Schein M, Condon RE. Management of secondary peritonitis. Ann Surg 1996; 224: 10-18.

  14. Wittmann DH. Symposium of intra-abdominal infections: Introduction. World J Surg 1990; 14: 145-7.

  15. Heemken R, Gandawidjaja L, Hau T. Peritonitis: Pathophysiology and local defense mechanisms. Hepatogastroenterology 1997; 44: 927-36.

  16. Koperna T, Schulz F. Prognosis and treatment of peritonitis. Do we need new scoring systems? Arch Surg 1996; 131: 180-6.

  17. Bosscha K, Van Vroonhoven THJ, Van der Werken CH. Surgical management of severe secondary peritonitis. Br J Surg 1999; 86: 1371-77.

  18. Billing A, Frohlich D, Schildberg FW. Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Br J Surg 1994; 81: 209-13.

  19. Wacha H, Linder MM, Feldman U, Wesh G et al. Mannheim peritonitis index prediction of risk of death from peritonitis: construction of a statistical and validation of an empirically based index. Theoretical Surgery 1987; 1: 169-77.

  20. Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: An evidence-based review. Crit Care Med 2004; 32: S513-S526.

  21. Cinat ME, Wilson SE, Din AM. Determinants for successful percutaneous image-guided drainage of intra-abdominal abscess. Arch Surg 2002; 137: 845-9.

  22. Kok KY, Yapp SK. Laparoscopic drainage of postoperative complicated intra-abdominal abscesses. Surg Laparosc Endosc Percutan Tech 2000; 10: 311-13.

  23. Mughal MM, Bancewicz J, Irving MH. Laparostomy: A technique for the management of intractable intraabdominal sepsis. Br J Surg 1986; 73: 253-9.

  24. Schein M. Planned re-operations and open management in critical intra-abdominal infections: Prospective personal experience in 52 cases. World J Surg 1991; 15: 537:45.

  25. Schein M, Hirshberg A, Hashmonai M. Current surgical management of severe intrabdominal infection. Surgery 1992; 112: 489-96.

  26. Wittmann DH, Aprahamian C, Bergstein JM. Etappenlavage: Advanced diffuse peritonitis managed by plannedmultiple laparotomies utilizing zippers, slide fastener, and Velcro analogue for temporary abdominal closure. World J Surg 1990; 14: 218-26.

  27. Gutierrez de la Peña C, Marquez R, Fakih F, et al. Simple closure or vagotomy and pyloroplasty for the treatment of a perforated duodenal ulcer: Comparison of results. Dig Surg 2000; 17: 225-8.

  28. García-Iñiguez JA, Fuentes-Orozco C, Muciño-Hernández MI, López-Ortega A, Sereno-Trabaldo S, González-Ojeda A. Complicaciones del manejo de la peritonitis secundaria con abdomen abierto contenido. Comparación de la “bolsa” de Bogotá vs. malla de polipropileno. Rev Gastroenterol Mex 2004; 69: 147-55.

  29. Lamme B, Boermeester MA, Reitsma JB, Mahler CW, Obertop H, Gouma DJ. Meta-analysis of relaparotomy for secondary peritonitis. Br DJ Surg 2002; 89: 1516-24.

  30. Lamme B, Boermeester MA, Belt EJ, Van Till JW, Gouma DJ, Obertop H. Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis. Br J Surg 2004; 91: 1046-54.

  31. Fuentes OC, Anaya PR, González OA, Arenas MH, Cabrera PC, Cervantes GG, Barrera ZLM. L-Alanyl-L-Glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr 2004; 23: 13-21.

  32. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993; 80: 205-9.

  33. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 2000; 12: 59-63.

  34. Weighardt H, Heidecke CD, Westerholt A, Emmanuilidis K, Maier S, Veit M, et al. Impared monocyte IL-12 production before surgery as a predictive factor for the lethal outcome of postoperative sepsis. Ann Surg 2002; 235: 560-7.

  35. Kahlke V, Schafmayer C, Schniewind B, Seegert D, Schreiber S, Schroder J. Are postoperative complications genetically determined by TNF-beta NcoI gene polymorphism?. Surgery 2004; 135: 365-73.

  36. Riese J, Woerner K, Zimmermann P, Denzel C, Hohenberger W, Haupt W. Association of a TNF-beta gene polymorphism with complications after major abdominal operations. Shock 2003; 19: 1-4.

  37. Fang XM, Schroder S, Hoeft A, Stuber F. Comparison of two polymorphism of the inlerleukine-1 receptor antagonist contributes to susceptibility to severe sepsis. Crit Care Med 1999; 27: 1330-4.

  38. Emmanuilidis K, Weighardt H, Matevossian E, Heidecke CD, Ulm K, Bartels H, Siewert JR, Holzmann B. Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: High serum IL-18 as an early predictive indicator of lethal outcome. Shock 2002; 18: 301-5.

  39. Arnalich F, Garcia-Palomero E, Lopez J, Jimenez M, Madero R, Renart J, Vazquez JJ, Montiel C. Predictive value of nuclear factor kappa-B activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000; 68: 1942-5.

  40. Beer S, Weighardt H, Emmanuilidis K, Harzenetter MD, Matevossian E, Heidecke CD, Bartels H, Siewert JR, Holzmann B. Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis. Crit Care Med 2002; 30: 1794-8.

  41. Wunder C, Eichelbronmer O, Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for prediction in severe sepsis? A comparison with APACHE II and SAPSII. Inflamm Res 2004; 53: 158-63.

  42. Riedemann NC, Guo RF, Ward AP. Novel strategies for the treatment of sepsis. Nat Med 2003; 9: 517-24.

  43. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003: 21: 335-76.

  44. Dellinger RF, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858-72.




2020     |     www.medigraphic.com